Combination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia – a report of five cases

Author： Fredly Hanne   Stapnes Bjørnsen Camilla   Gjertsen Bjørn Tore   Bruserud Øystein  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.15, Iss.5, 2010-10, pp. : 338-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

By Kuendgen Andrea   Knipp Sabine   Fox Frank   Strupp Corinna   Hildebrandt Barbara   Steidl Christian   Germing Ulrich   Haas Rainer   Gattermann Norbert  

Annals of Hematology, Vol. 84, Iss. 1, 2005-12 ,pp. : 61-66

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell rescue for acute myeloid leukemia remains a safe, effective, and valid option

By Hwang Y.K.W.   Goh Y.T.   Linn Y.C.   Tan C.H.   Tan H.C.P.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2464-2466

Elsevier

Access to resources Recommend Favorite

Reduced serum retinol-binding protein levels in patients with de novo acute myeloid leukaemia

By Su Long   Gao SuJun   Tan YeHui   Yang Yan   Liu XiaoLiang   Yu Ping   Lin Hai   Li Wei  

Hematology, Vol. 18, Iss. 6, 2013-11 ,pp. : 322-326

Maney Publishing

Access to resources Recommend Favorite

Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia

By Erikci Alev Akyol   Ozturk Ahmet   Karagoz Bulent   Bilgi Oguz   Turken Orhan   Top Cihan   Kandemir E. Gokhan  

Hematology, Vol. 13, Iss. 5, 2008-10 ,pp. : 289-292

Maney Publishing

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Development of Suberoylanilide Hydroxamic Acid (SAHA) for the Treatment of Cancers

By Richon V.M.   Zhou X.   Rifkind R.A.   Marks P.A.  

Blood Cells, Molecules, and Diseases, Vol. 27, Iss. 1, 2001-01 ,pp. : 260-264

Academic Press

Access to resources Recommend Favorite